Ovid Therapeutics Inc (OVID)

1.66 +9.60%

Ovid Therapeutics Inc (OVID) is currently trading at $1.66. This represents a gain of 9.6% from the previous session. With a market capitalization of $0.21B, OVID is a key component of the Health Care sector. Investors looking to trade OVID should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Get 15 Free Stocks on Moomoo → T&Cs Apply. Trade OVID commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Ovid Therapeutics Inc (OVID) shows a bullish trend. Analysts are watching the 1.67 level closely.

Fundamentals
Mkt Cap0.21B
P/E Ratio0.0000
Volume872,040
Others Watching (By Market Cap)
ORGO
Organogenesis H $4.04
+0.25% FDMT
4D Molecular Th $10.05
-0.20% ALT
Altimmune Inc $4.55
-0.55% VNDA
Vanda Pharmaceu $8.65
+5.88% AQST
Aquestive Thera $4.21
+2.57%
60-Day Technical Chart
Advanced Charting

Need more indicators for OVID? Use the world's #1 platform.

Open OVID on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $2
Metric OVID
+9.60% 		GERN
-18.46% 		BTBT
+5.65% 		ATUS
+1.13%
Price $1.66 $1.59 $1.78 $1.79
Mkt Cap $0.21B $1.01B $0.58B $0.84B
- View → View → View →
Latest Headlines
Brain disorder drug developer Ovid lines up three investor talks Stock Titan • Feb 25, 2026 Ovid Therapeutics (OVID) Is Up 42.98% in One Week: What You Should Know Yahoo Finance • Oct 6, 2025 Roundup: Ovid Therapeutics and Metagenomi Announce 2025 Third Quarter Results and Leadership Updates Pharmaceutical Executive • Nov 13, 2025 Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why Stocktwits • Oct 3, 2025 Is Ovid Therapeutics (OVID) One of the Best Fast Growing Penny Stocks to Buy According to Analysts? Finviz • Jan 30, 2026
● Gemini Agentic AI Analyst Insight for OVID
Market Education
View All Articles →
External Research